The cystic fibrosis airway microbiome

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 3, 2013, Pages

  Lynch, Susan V ^a   Bruce, Kenneth D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHUS; CELLULAR IMMUNITY; CYSTIC FIBROSIS; HUMAN; IMMUNOLOGY; METAGENOME; MICROBIOLOGY; PHYSIOLOGY; REVIEW;

BRONCHI; CYSTIC FIBROSIS; HUMANS; IMMUNITY, CELLULAR; METAGENOME;

EID: 84885809153     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a009738     Document Type: Article

References (22)

1. Arumugam M., Raes J, Pelletier E, Le Paslier D, Yamada T, Mende D.R., Fernandes GR, Tap J, Bruls T, Batto JM, et al. 2011. Enterotypes of the human gut microbiome. Nature 473: 174-180.
2. Collins FS. 1992. Cystic fibrosis:Molecular biology and therapeutic implications. Science 256: 774-779.
3. Cox M.J., Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U., Andersen GL, Brown R, Fujimura KE, et al. 2010. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS ONE 5: e11044.
4. Eckburg P.B., Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. 2005. Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
5. Goddard A.F., Staudinger BJ, Dowd SE, Joshi-Datar A, Wolcott R.D., Aitken ML, Fligner CL, Singh PK. 2012. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci 109: 13769-13774.
6. Harris J.K., De Groote MA, Sagel SD, Zemanick ET, Kapsner R, Penvari C, Kaess H, Deterding RR, Accurso FJ, Pace NR. 2007. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci 104: 20529-20533.
7. Kharazmi A. 1991. Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa. Immunol Lett 30: 201-205.
8. Klepac-Ceraj V, Lemon KP, Martin TR, Allgaier M, Kembel SW, Knapp AA, Lory S, Brodie EL, Lynch SV, Bohannan B.J., et al. 2010. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol 12: 1293-1303.
9. Ley R.E., Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc Natl Acad Sci 102: 11070-11075.
10. Michail S., Durbin M, Turner D, Griffiths AM, Mack DR, Hyams J., Leleiko N, Kenche H, Stolfi A, Wine E. 2011. Alterations in the gut microbiome of childrenwith severe ulcerative colitis. Inflamm Bowel Dis doi: 10.1002/ibd. 22860.
11. Mowat E., Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw M.J., Brockhurst MA, Winstanley C. 2011. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am J Respir Crit Care Med 183: 1674-1679.
12. Palmer C., Bik EM, DiGiulio DB, Relman DA, Brown PO. 2007. Development of the human infant intestinal microbiota. PLoS Biol 5: e177.
13. Quinton PM. 2001. The neglected ion: HCO3. Nat Med 7: 292-293.
14. Riordan JR. 2008. CFTR function and prospects for therapy. Annu Rev Biochem 77: 701-726.
15. Rogers G.B., Hart CA, Mason JR, Hughes M, Walshaw MJ, Bruce KD. 2003. Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 41: 3548-3558.
16. Rogers G.B., Carroll MP, Serisier DJ, Hockey PM, Jones G, Bruce KD. 2004. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 42: 5176-5183.
17. Thiennimitr P., Winter SE, Winter MG, Xavier MN, Tolstikov V, Huseby DL, Sterzenbach T, Tsolis RM, Roth JR, Baumler AJ. 2011. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc Natl Acad Sci 108: 17480-17485.
18. Turnbaugh P.J., Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
19. Walker A.W., Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, Brostoff J, Parkhill J, Dougan G, Petrovska L. 2011. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 11: 7.
20. Winter S.E., Thiennimitr P, Winter MG, Butler BP, Huseby DL, Crawford RW, Russell JM, Bevins CL, Adams L.G., Tsolis RM, et al. 2010. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467: 426-429.
21. Wu G.D., Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, KnightsD, WaltersWA, Knight R, et al. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105-108.
22. Zhao J., Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino J.F., Cavalcoli JD, VanDevanter DR, Murray S, Li J.Z., et al. 2012. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci 109: 5809-5814.